Dr. James Grotta

[vc_row][vc_column el_align=”align-center” css=”.vc_custom_1517945355852{padding-right: 350px !important;padding-left: 350px !important;}”][vc_single_image image=”1547″ alignment=”center” css=”.vc_custom_1517946006256{padding-right: 50px !important;padding-left: 50px !important;}”][/vc_column][/vc_row][vc_row][vc_column css=”.vc_custom_1518102945132{padding-right: 250px !important;padding-left: 250px !important;}”][vc_custom_heading text=”Dr. James Grotta has devoted 40 years to preclinical and clinical research in acute stroke therapy. A consistent theme throughout his research has been insistence on early treatment which stems from his animal modeling and NINDS tPA study experience which clearly demonstrated the importance of ultra-early treatment to achieve maximal benefit. ” font_container=”tag:h4|font_size:22|text_align:left”][vc_custom_heading text=”Consistent with this philosophy, Dr. Grotta has recently launched, and personally staffs, the first Mobile Stroke Unit in the U.S. to deliver acute stroke treatment in the pre-hospital environment, and is funded by the Patient Centered Outcomes Research Institute to conduct a prospective multicenter comparative effectiveness study of this novel approach to acute stroke treatment. ” font_container=”tag:h4|font_size:22|text_align:left”][vc_custom_heading text=”Since coming to UT Houston Medical School in 1979, he built and directed one of the largest clinical stroke research and training programs in the U.S., and was chairman of the department of Neurology from 2006-14. He has published over 370 scientific manuscripts in peer reviewed journals, and edits the most authoritative textbook in the field.” font_container=”tag:h4|font_size:22|text_align:left”][/vc_column][/vc_row]

5T Conference 
October 6th-8th 2022
Fairmont Banff Springs Hotel
Alberta, Canada